MondayMay 08, 2023 3:01 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid commercial adoption and distribution of its patented DehydraTECH(TM) absorption technology, which is designed to improve oral uptake. Statistics show that some 7 million people die every year from cigarette smoking, and alternatives for nicotine delivery…

Continue Reading

MondayMay 08, 2023 2:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Discontinues Alliance with Mexico-Based Freight Company

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App offers a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping within the USMCA region, has discontinued its alliance with Zaro Transportation. Fr8App is an industry-leading freight-matching platform powered by AI and machine-learning. “At Fr8Tech, we entered into the strategic alliance with Zaro expecting to be able to reach a certain level of sales at margins that we expected would be lower than our other business segments but at acceptable levels,” said Fr8App CEO Javier Selgas in the press release. “Our alliance with Zaro enhanced Zaro’s ability to provide…

Continue Reading

MondayMay 08, 2023 1:56 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Board Appointment of Pharma and Biotech Industry Veteran Dr. Bettina M. Cockroft

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its appointment of Bettina M. Cockroft, M.D., M.B.A., to its board of directors. Dr. Cockroft, a well-established industry executive with over 30 years of experience in the biopharmaceutical industry with clinical development expertise across multiple therapeutic areas, will serve as an independent director. “On behalf of the CNS Pharmaceuticals board and management, we are thrilled to welcome Dr. Cockroft to the board. Her appointment adds deep scientific, clinical and operational expertise, and…

Continue Reading

MondayMay 08, 2023 11:47 am

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Releases Q1 2023 Financial, Corporate Report, Announces Earnings Call

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is reporting on its financial results for the quarter ended March 31, 2023; the company also announced that it will host an earning conference call and webcast on May 9, 2023. According to the report, Energy Fuels sold 300,000 pounds of uranium resulting in a gross margin of 58% and 79,344 pounds of vanadium totaling a 37% gross margin of 37%; the company also sold its Alta Mesa property for a total gain of $116.45 million. The report showed that UUUU’s working capital grew with total assets increasing and total liabilities decreasing. Other highlights…

Continue Reading

FridayMay 05, 2023 1:17 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Inks Stiff Person Syndrome Clinical Trial Agreement with Mayo Clinic

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, and its subsidiary Adimune(TM) Inc. announced a clinical trial agreement with Mayo Clinic. The clinical trial, which is designed to advance clinical studies targeting autoimmune diseases of the central nervous system (“CNS”), is expected to begin this year with an estimated 10 to 15 patients, some of whom may also suffer from type-1 diabetes; the initial focus of the study will be on the autoimmune disease Stiff Person Syndrome (“SPS”). According to the announcement, Adimune, which was created to lead Aditxt’s immune…

Continue Reading

ThursdayMay 04, 2023 1:11 pm

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Appoints Seasoned Veteran as Customer Program Director on Detroit Team

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, announced that Luis Gonçalves, formerly with Honda and GM, has joined its Detroit team as director of customer programs. Goncalves brings more than a decade of experience in automotive technology deployment, which will be invaluable as Cepton ramps up its volume production. In his new role, Gonçalves will lead Cepton’s Detroit automotive customer programs and support volume production ramp through Cepton’s flagship ADAS lidar program with its lead OEM customer as well as future production awards from other automotive customers. In addition, he will also manage onsite support to…

Continue Reading

ThursdayMay 04, 2023 11:28 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Customer Pricing for Two Models, Notes 1-for 25 Reverse Stock Split

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is releasing customer pricing for its Class 1 EV cargo van; the company announced that the starting price for the EV van will be $34,500 and the class 3 EV cab chassis trucks will start at $68,500. The announcement comes as the company has delivered 19 EV cargo vans to date with 20 more planned for this month, along with an anticipated purchase order for 200 more expected this month. The company previously announced that it had received a 1,000-unit class 3 EV truck purchase order from the Randy Marion…

Continue Reading

ThursdayMay 04, 2023 9:00 am

TinyGemsBreaks – Vision Energy Corp. (VENG) Confirms Current Trading Status

Vision Energy (OTC: VENG) has announced that the OTC Markets Group (“OTC”) removed the “Caveat Emptor” designation from the company’s profile on April 27, 2023. As previously disclosed, the OTC, on Jan. 20, 2023, labeled the company with such designation. The removal indicates that Vision Energy demonstrated to the OTC that there is no longer a public interest concern. As a result, there is now an active market without restrictions on the company’s securities. To view the full press release, visit https://ibn.fm/KEPNh About Vision Energy Corp. Vision Energy identifies energy commodities and focuses on originating and developing energy infrastructure projects…

Continue Reading

WednesdayMay 03, 2023 12:27 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Retains Analytics Firm, Investigates Possible Naked Short Selling

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is investigating potential naked short selling of its stock. As part of that process, the company has retained Shareholder Intelligence Services LLC (ShareIntel), a well-known analytics firm. ShareIntel will be evaluating trading patterns of CNSP stock as part of the investigation. “While we are pleased to see the significant price appreciation in our stock as well as an increased high volume of trading activities, our shareholders have expressed concerns that our stock may be…

Continue Reading

WednesdayMay 03, 2023 11:51 am

TinyGemsBreaks— Mullen Automotive Inc. (NASDAQ: MULN) Releases Corporate Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on its manufacturing activities in its two facilities and in producing its line of EVS. The company also noted that as of April 30, 2023, it had available cash of $116.1 million and has received $263 million in purchase orders for its Mullen class 1 and class 3 EV vans and trucks from Randy Marion Automotive Group. The company’s Bollinger Motors is moving forward on producing its class 4­–6 commercial vehicles and B1 SUV and B2 pick-up truck; Bollinger Motors B4 chassis cab engineering is 90% complete and…

Continue Reading

Contact us: (512) 354-7000